Production (Stage)
Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -44.43% | -38.81% | -32.11% | -23.42% | -11.79% |
| Total Depreciation and Amortization | -33.02% | -6.10% | 29.26% | 29.96% | 27.15% |
| Total Amortization of Deferred Charges | 651.41% | 324.61% | 128.90% | 44.40% | -42.63% |
| Total Other Non-Cash Items | 451.99% | 304.31% | 94.38% | 35.33% | -5.51% |
| Change in Net Operating Assets | 134.88% | -273.42% | -203.55% | -209.80% | -227.74% |
| Cash from Operations | 59.15% | -24.15% | -417.52% | -192.70% | -88.16% |
| Capital Expenditure | -4.46% | 66.67% | 89.33% | 87.48% | 87.27% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 96.83% | 85.78% | 78.78% | 60.61% | 46.07% |
| Cash from Investing | 94.38% | 85.07% | 79.27% | 62.57% | 50.01% |
| Total Debt Issued | -56.40% | -85.52% | -92.80% | -81.60% | -66.67% |
| Total Debt Repaid | 63.29% | 75.53% | 78.76% | 75.43% | 71.89% |
| Issuance of Common Stock | -- | 0.00% | -- | 181.43% | 40.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00% | -- | -235.65% | -67.83% |
| Cash from Financing | -97.11% | -23.21% | 326.22% | 92.00% | 23.55% |
| Foreign Exchange rate Adjustments | -204.27% | 386.36% | 417.07% | 401.09% | 364.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -295.19% | -6.76% | 144.11% | 207.92% | 224.92% |